Assessing the Pros of Patient-Reported Outcomes in Early Breast Cancer
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Lola Fayanju, MD, MA, MPHS
Patient-reported outcomes, or PROs, are not only an efficient way to measure treatment effects, but they can also help us improve care for patients with early breast cancer. Dr. Charles Turck is joined by Dr. Lola Fa…
The Importance of Diversity in Breast Cancer Clinical Trials
Dr. Lola Fayanju is the Helen O. Dickens Presidential Associate Professor at the Perelman School of Medicine at the University of Pennsylvania, where she is also chief of breast surgery at Penn Medicine, as well as surgical director of the Rena Rowan Breast Center. Her research focuses on health di…
Breast Cancer Risk and Race
Dr. Lola Fayanju is assistant professor of surgery at the Duke University School of Medicine. In addition to treating people with breast cancer surgery, Dr. Fayanju’s research interests include using big data and sophisticated analyses to reduce disparities in outcomes after breast cancer diagnoses…
Breast Cancer and Race: Disparities and Mental Health Effects
Dr. Lola Fayanju is assistant professor of surgery at the Duke University School of Medicine. In addition to treating people with breast cancer surgery, Dr. Fayanju’s research interests include using big data and sophisticated analyses to reduce disparities in outcomes after breast cancer diagnoses…
Breast Cancer Screening
In this episode, Dr. Williams is joined by Dr. Lola Fayanju, Dr. Amber-Nicole Bird, and Dr. Christine Edmonds in a discussion focusing on the diagnosing and early management of breast cancer. the importance of mammograms and screening. and treatment options.
E14: Leadership and Imposter Syndrome in Surgery
In this episode, Dr Dante Yeh is joined by Lola Fayanju, MD, MA, MPHS, FACS, from The University of Pennsylvania, Philadelphia, PA. They discuss Dr Fayanju’s recent study on imposter syndrome, an internalized sense of incompetence and not belonging. The study found that female physicians were more …
Closing Racial Disparities in Breast Cancer Through Data with Dr. Lola Fayanju
Differences in treatment delivery and receipt are estimated to account for about 50 percent of the racial disparities seen in breast cancer-associated mortality.
In this latest episode of Investigating Breast Cancer, Dr. Lola Fayanju discusses her work to understand how to close this gap. BCRF in…
SSO Education Series: Invasive Lobular Carcinoma
In this episode, Dr. Anna Weiss from the University of Rochester moderates a discussion with Dr. Lola Fayanju at the University of Pennsylvania, Dr. Rita Mukhtar at UCSF and Laurie B. Hutcheson from The Lobular Breast Cancer Alliance about surgical management of invasive lobular carcinoma. This his…
Treatment De-escalation for Favorable Risk Breast Cancer
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be based off a JCO OP edit…
เครื่องมือค้นหาพอดแคสต์
คุณสามารถใช้เว็บไซต์ของเราเพื่อค้นหาพอดแคสต์ของ3,827,261และตอนของ196,226,820ตามบุคคล สถานที่ หรือหัวข้อ
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
